Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Transferrin receptor targeting by de novo sheet extension
2021 StandoutNobel
Structure-based inhibitors of amyloid beta core suggest a common interface with tau
2019
Roles of tau protein in health and disease
2017
Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
2017
Alzheimer's disease: synapses gone cold
2011
The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain
2019 Standout
A pupal transcriptomic screen identifies Ral as a target of store-operated calcium entry in Drosophila neurons
2017 StandoutNobel
Origins of Alzheimerʼs disease
2012
Genetic modulation of the pharmacological treatment of pain
2009
The Amyloid-β Pathway in Alzheimer’s Disease
2021
Alzheimer Mechanisms and Therapeutic Strategies
2012
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
2016
Induced Pluripotent Stem Cells: Past, Present, and Future
2012 StandoutNobel
Autophagic degradation of tau in primary neurons and its enhancement by trehalose
2011
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
The glymphatic pathway in neurological disorders
2018 Standout
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone
2018 Nature
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Modeling familial Alzheimer's disease with induced pluripotent stem cells
2011 StandoutNobel
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
2011
Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse
2016
Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation
2012
Optogenetics: 10 years of microbial opsins in neuroscience
2015 Standout
Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids
2012
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
2014
Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease
2017
Nuclear Receptors License Phagocytosis by Trem2+Myeloid Cells in Mouse Models of Alzheimer's Disease
2015
Tau in physiology and pathology
2015 Standout
A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s disease
2012
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β
2012 Nature
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector
2018
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
2016 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
2012
Gut microbiome alterations in Alzheimer’s disease
2017 Standout
Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
2012
Amyloid‐beta oligomerization in Alzheimer dementia versus high‐pathology controls
2012
Deciphering the mechanism underlying late-onset Alzheimer disease
2012
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Alzheimer's disease
2016 Standout
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
2013
The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
2015
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
2012
Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers
2014
Resolving controversies on the path to Alzheimer's therapeutics
2011
The Amyloid State of Proteins in Human Diseases
2012 Standout
Design of amyloidogenic peptide traps
2024 StandoutNobel
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
2015
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons
2014
Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β
2013
Non-specific low back pain
2011 Standout
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
Tau Kinetics in Neurons and the Human Central Nervous System
2018
Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease
2015
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
2018
Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
2011
Lipids and Alzheimer’s Disease
2020
Alzheimer's disease
2017 Standout
Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
2015
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
2012
Light and heat control over secondary structure and amyloid-like fiber formation in an overcrowded-alkene-modified Trp zipper
2015 StandoutNobel
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity
2019 StandoutNobel
Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease
2013
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Regulation of Caenorhabditis elegans neuronal polarity by heterochronic genes
2019 StandoutNobel
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
2015 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy
2016
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity
2014
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
A water-soluble metal–organic complex array as a multinuclear heterometallic peptide amphiphile that shows unconventional anion dependency in its self-assembly
2015 StandoutNobel
Emerging Therapeutics for Alzheimer's Disease
2014
Amyloid-β and Tau
2014 Standout
Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition
2015
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Metabotropic NMDA receptor function is required for β-amyloid–induced synaptic depression
2013
ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease
2020
Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma
2017
Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
2016
Works of Ming Jin being referenced
Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain
2018
Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers
2013
Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia
2012
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
2011
C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death
2015
Pharmacogenomics as Molecular Autopsy for Forensic Toxicology: Genotyping Cytochrome P450 3A4*1B and 3A5*3 for 25 Fentanyl Cases
2005
Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
2014
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
2011